market-trends is the sole category represented across all 2 tracked stories. agilon health is most often covered alongside CMS, which appears in 1 of these 2 stories. The 9-day window averages about 1.6 stories each week. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about agilon health
market-trends is the sole category represented across all 2 tracked stories. agilon health is most often covered alongside CMS, which appears in 1 of these 2 stories. The 9-day window averages about 1.6 stories each week. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window. The 5.5 average consequence score is below the beat benchmark of 5.9 in the same window. We currently track 2 Healthcare stories that mention agilon health, published between March 4, 2026 and March 12, 2026.
Stories tracked
2
Per week
1.6
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 206 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering agilon health. Shared-story counts are live from our verified record — not editorial picks.
agilon health (AGL) shares experienced a significant decline on March 12, 2026, extending a period of high volatility following a disappointing earnings report. Despite robust revenue growth, the company's persistent struggle with medical cost management and earnings misses continues to weigh on investor confidence.
Shares of agilon health (AGL) and Datadog (DDOG) experienced significant price appreciation on March 4, 2026, following a series of positive financial disclosures. The rally highlights a growing market confidence in value-based care models and the critical observability infrastructure required to scale them.